Skip to main content
Premium Trial:

Request an Annual Quote

FDA, EMEA Release Joint Pharmacogenomics Data-Submission Guidance

NEW YORK, June 1 (GenomeWeb News) - US and European drug regulators today said they have agreed to a joint procedure that drug makers can follow to voluntarily submit pharmacogenomic data to both agencies.

 

The document, which can be found here, could benefit pharmaceutical companies interested in simultaneously selling products in Europe and the US that have pharmacogenomic components.

 

Specifically, the European Medicines Agency and the US Food and Drug Administration today released a set of "guiding principles" describing how they will process drug makers' requests to jointly meet with both agencies about voluntary genomic data submission.

 

The guiding principles have a list of definitions agreed to by the agencies, and a flowchart describing how voluntary submissions would be procssed. The FDA's Interdisciplinary Pharmacogenomic Review Group and the EMEA's Pharmacogenetics Working Party will review the data submission packages.

 

The FDA and the EMEA have issued industry guidance on pharmacogenomic data submissions and briefing meetings in the past. While researchers are not required to submit pharmacogenomic data to health authorities in most cases, voluntary submissions are encouraged to help regulators become familiar with issues arising in drug development.

 

The FDA published guidelines on voluntary submissions in 2004. The FDA and EMEA informally met at the time to help the agencies synchronize their pharmacogenomic goals and strategies. The most recent guidance for voluntary submissions on the FDA web site is dated March 2005.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.